FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061807782> ?p ?o ?g. }

• W2061807782 endingPage "2180" @default.
• W2061807782 startingPage "2171" @default.
• W2061807782 abstract "BACKGROUND High-dose chemotherapy with autologous hematopoietic progenitor cell (HPC) transplantation improves survival for patients with multiple myeloma (MM); however, most patients develop recurrent disease after undergoing transplantation, and new treatment approaches are needed. The objective of this retrospective review of autologous HPC transplantation for patients with MM was to evaluate the impact of conditioning regimens and posttransplantation therapy on survival. METHODS The authors reviewed 112 patients with MM who received autologous HPC grafts at their institution. Between June 1992 and August 2001, 54 patients received busulfan, cyclophosphamide, and etoposide (Bu/Cy/VP-16), and 58 patients received high-dose melphalan (MEL-200) followed by autologous HPC transplantation. After transplantation, 36 patients received thalidomide for maintenance or salvage therapy, and 76 patients received no posttransplantation thalidomide. RESULTS At a median follow-up of 58 months, the median survival was 54 months. There was no statistically significant difference noted with regard to response to conditioning regimen, progression-free survival, or overall survival between the Bu/Cy/VP-16 and MEL-200 cohorts. Patients who received thalidomide after transplantation had improved median survival (65.5 months) compared with patients who did not receive thalidomide (44.5 months; P = .09). When they were separated according to reasons for thalidomide use, patients who received thalidomide as maintenance had improved overall survival compared with patients who received thalidomide as salvage (65 months vs. 54 months; P = .05). CONCLUSIONS Combination chemotherapy provided no advantage over high-dose melphalan in patients with MM who underwent autologous HPC transplantation. The posttransplantation use of thalidomide seemed to improve the survival of patients compared with historical controls from the prethalidomide era. Further prospective trials are underway to confirm the benefit of thalidomide in the posttransplantation setting. Cancer 2006. © 2006 American Cancer Society." @default.
• W2061807782 created "2016-06-24" @default.
• W2061807782 creator A5011386306 @default.
• W2061807782 creator A5018311470 @default.
• W2061807782 creator A5023276777 @default.
• W2061807782 creator A5052203408 @default.
• W2061807782 creator A5059653463 @default.
• W2061807782 creator A5064293376 @default.
• W2061807782 creator A5079310177 @default.
• W2061807782 date "2006-01-01" @default.
• W2061807782 modified "2023-09-27" @default.
• W2061807782 title "Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma" @default.
• W2061807782 cites W1977950751 @default.
• W2061807782 cites W1978377409 @default.
• W2061807782 cites W1984996099 @default.
• W2061807782 cites W1985147506 @default.
• W2061807782 cites W1986357281 @default.
• W2061807782 cites W2018803923 @default.
• W2061807782 cites W2027646098 @default.
• W2061807782 cites W20342555 @default.
• W2061807782 cites W2060881421 @default.
• W2061807782 cites W2075134261 @default.
• W2061807782 cites W2076756910 @default.
• W2061807782 cites W2078758435 @default.
• W2061807782 cites W2080264915 @default.
• W2061807782 cites W2092718117 @default.
• W2061807782 cites W2102591890 @default.
• W2061807782 cites W2108601475 @default.
• W2061807782 cites W2113101033 @default.
• W2061807782 cites W2125559109 @default.
• W2061807782 cites W2127143739 @default.
• W2061807782 cites W2128608897 @default.
• W2061807782 cites W2132242107 @default.
• W2061807782 cites W2135430006 @default.
• W2061807782 cites W2159746652 @default.
• W2061807782 cites W2161157025 @default.
• W2061807782 cites W2271876496 @default.
• W2061807782 cites W2316160054 @default.
• W2061807782 cites W2321655863 @default.
• W2061807782 cites W3145716452 @default.
• W2061807782 cites W4236730981 @default.
• W2061807782 cites W4237181574 @default.
• W2061807782 cites W4241368398 @default.
• W2061807782 cites W4241442958 @default.
• W2061807782 cites W4251865761 @default.
• W2061807782 cites W4376542883 @default.
• W2061807782 cites W4378951223 @default.
• W2061807782 cites W2044403774 @default.
• W2061807782 doi "https://doi.org/10.1002/cncr.21852" @default.
• W2061807782 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16598756" @default.
• W2061807782 hasPublicationYear "2006" @default.
• W2061807782 type Work @default.
• W2061807782 sameAs 2061807782 @default.
• W2061807782 citedByCount "46" @default.
• W2061807782 countsByYear W20618077822012 @default.
• W2061807782 countsByYear W20618077822013 @default.
• W2061807782 countsByYear W20618077822014 @default.
• W2061807782 countsByYear W20618077822015 @default.
• W2061807782 countsByYear W20618077822016 @default.
• W2061807782 countsByYear W20618077822018 @default.
• W2061807782 countsByYear W20618077822019 @default.
• W2061807782 countsByYear W20618077822022 @default.
• W2061807782 countsByYear W20618077822023 @default.
• W2061807782 crossrefType "journal-article" @default.
• W2061807782 hasAuthorship W2061807782A5011386306 @default.
• W2061807782 hasAuthorship W2061807782A5018311470 @default.
• W2061807782 hasAuthorship W2061807782A5023276777 @default.
• W2061807782 hasAuthorship W2061807782A5052203408 @default.
• W2061807782 hasAuthorship W2061807782A5059653463 @default.
• W2061807782 hasAuthorship W2061807782A5064293376 @default.
• W2061807782 hasAuthorship W2061807782A5079310177 @default.
• W2061807782 hasBestOaLocation W20618077821 @default.
• W2061807782 hasConcept C126322002 @default.
• W2061807782 hasConcept C141071460 @default.
• W2061807782 hasConcept C143998085 @default.
• W2061807782 hasConcept C2776364478 @default.
• W2061807782 hasConcept C2776694085 @default.
• W2061807782 hasConcept C2777408962 @default.
• W2061807782 hasConcept C2778119113 @default.
• W2061807782 hasConcept C2778684742 @default.
• W2061807782 hasConcept C2779050716 @default.
• W2061807782 hasConcept C2779609412 @default.
• W2061807782 hasConcept C2780611847 @default.
• W2061807782 hasConcept C2780775027 @default.
• W2061807782 hasConcept C2781413609 @default.
• W2061807782 hasConcept C2911091166 @default.
• W2061807782 hasConcept C71924100 @default.
• W2061807782 hasConceptScore W2061807782C126322002 @default.
• W2061807782 hasConceptScore W2061807782C141071460 @default.
• W2061807782 hasConceptScore W2061807782C143998085 @default.
• W2061807782 hasConceptScore W2061807782C2776364478 @default.
• W2061807782 hasConceptScore W2061807782C2776694085 @default.
• W2061807782 hasConceptScore W2061807782C2777408962 @default.
• W2061807782 hasConceptScore W2061807782C2778119113 @default.
• W2061807782 hasConceptScore W2061807782C2778684742 @default.
• W2061807782 hasConceptScore W2061807782C2779050716 @default.
• W2061807782 hasConceptScore W2061807782C2779609412 @default.
• W2061807782 hasConceptScore W2061807782C2780611847 @default.

• next